SE0100195L - Utvärderingsförfaranden för antitumöraktivitet - Google Patents

Utvärderingsförfaranden för antitumöraktivitet

Info

Publication number
SE0100195L
SE0100195L SE0100195A SE0100195A SE0100195L SE 0100195 L SE0100195 L SE 0100195L SE 0100195 A SE0100195 A SE 0100195A SE 0100195 A SE0100195 A SE 0100195A SE 0100195 L SE0100195 L SE 0100195L
Authority
SE
Sweden
Prior art keywords
tumor activity
evaluation procedures
koji
glucan
fermenting
Prior art date
Application number
SE0100195A
Other languages
English (en)
Swedish (sv)
Other versions
SE0100195D0 (sv
Inventor
Kozo Niwa
Original Assignee
Kozo Niwa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kozo Niwa filed Critical Kozo Niwa
Publication of SE0100195L publication Critical patent/SE0100195L/
Publication of SE0100195D0 publication Critical patent/SE0100195D0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
SE0100195A 1998-09-17 2001-01-24 Utvärderingsförfaranden för antitumöraktivitet SE0100195D0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26375398 1998-09-17
JP10323374A JP2000159682A (ja) 1998-09-17 1998-11-13 生薬の抗腫瘍活性強化方法、抗腫瘍活性強化生薬含有組成物、生薬処理の抗腫瘍有効性評価方法、および生薬の抗腫瘍有効性評価方法

Publications (2)

Publication Number Publication Date
SE0100195L true SE0100195L (sv) 2001-01-24
SE0100195D0 SE0100195D0 (sv) 2001-01-24

Family

ID=26546176

Family Applications (2)

Application Number Title Priority Date Filing Date
SE9903307A SE9903307L (sv) 1998-09-17 1999-09-16 Förstärkning av antitumöraktivitet hos naturdroger från svamp
SE0100195A SE0100195D0 (sv) 1998-09-17 2001-01-24 Utvärderingsförfaranden för antitumöraktivitet

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE9903307A SE9903307L (sv) 1998-09-17 1999-09-16 Förstärkning av antitumöraktivitet hos naturdroger från svamp

Country Status (19)

Country Link
JP (1) JP2000159682A ( )
KR (1) KR20000023206A ( )
CN (1) CN1255376A ( )
AU (1) AU4486299A ( )
BE (1) BE1012725A5 ( )
CA (1) CA2282234A1 ( )
DE (1) DE19944695A1 ( )
DK (1) DK199901235A ( )
ES (1) ES2155802B1 ( )
FR (2) FR2783426A1 ( )
GB (2) GB9920710D0 ( )
ID (1) ID23150A ( )
IL (1) IL131722A0 ( )
IS (1) IS5183A ( )
IT (1) IT1307267B1 ( )
NL (2) NL1013049C2 ( )
NO (1) NO994463L ( )
SE (2) SE9903307L ( )
SG (1) SG76631A1 ( )

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60218299T2 (de) * 2001-04-27 2007-10-31 Ajinomoto Co., Inc. Eine Dispersion aus Beta-Glukan enthaltenden hochfeinen Partikel, ein entsprechender Herstellungsprozess und die Verwendung der Dispersion
WO2002090559A1 (en) * 2001-05-07 2002-11-14 Biohub Co., Ltd. A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
JP4499979B2 (ja) * 2001-05-21 2010-07-14 コンビ株式会社 病原菌感染抑制用組成物
JP4561098B2 (ja) * 2001-06-01 2010-10-13 味の素株式会社 糖尿病用薬剤
KR100971599B1 (ko) 2002-05-15 2010-07-20 비에이취엔 가부시끼가이샤 혈관 관련 질환의 예방 또는 치료를 위한 조성물
JP4826696B2 (ja) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 血管新生阻害剤
JP4681801B2 (ja) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 血管新生阻害剤およびその製造方法
JP2005089417A (ja) * 2003-09-19 2005-04-07 Noevir Co Ltd 糖尿病予防・治療用組成物
JP4587441B2 (ja) * 2004-02-12 2010-11-24 株式会社クレハ 新規な糖尿病治療剤および食品
JP5034071B2 (ja) * 2004-09-17 2012-09-26 株式会社Ｓ・Ｓ・Ｉ 乳癌を抑制するカワリハラタケ抽出物
JP2006273835A (ja) * 2005-03-04 2006-10-12 Michishi Tani 悪性腫瘍治療剤及びそれを含む飲食品
US20120128856A1 (en) * 2009-07-31 2012-05-24 Ming East-West, Llc Maitake mushroom coffee
WO2011081024A1 (ja) * 2009-12-29 2011-07-07 株式会社富士見養蜂園 旨味食品及びその製造方法
CN106309511A (zh) * 2016-08-30 2017-01-11 青海民族大学 圆孢蘑菇抑制cdc25酶有效部位及制法和应用
CN106333969A (zh) * 2016-08-30 2017-01-18 青海民族大学 圆孢蘑菇抑制hdac1酶有效部位及制法和应用
US20200397817A1 (en) * 2017-11-30 2020-12-24 SHIEH, Darbin Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102646421B1 (ko) * 2020-12-16 2024-03-12 대한민국 잎새버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102602787B1 (ko) * 2020-12-16 2023-11-17 대한민국 꽃송이버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102584680B1 (ko) * 2020-12-17 2023-10-06 대한민국 생리활성 및 영양성분이 증가된 표고버섯차 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5276413A (en) * 1975-12-18 1977-06-27 Kureha Chem Ind Co Ltd Production of oncostatic substances
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (de) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Energetische anregung biologischer arzneimittel
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPH02203765A (ja) * 1989-02-02 1990-08-13 Nippon Beet Sugar Mfg Co Ltd 抗腫瘍機能を有する食品及びその製造法
JP3357383B2 (ja) * 1991-08-14 2002-12-16 昌宏 黒田 低分子化植物性組成物
JP2955126B2 (ja) * 1992-06-22 1999-10-04 笑代 丹羽 医薬用油性製剤、食品用油性製剤およびそれらの製造方法
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Also Published As

Publication number Publication date
ID23150A (id) 2000-03-23
NO994463L (no) 2000-03-20
ES2155802A1 (es) 2001-05-16
IS5183A (is) 2000-03-17
FR2783426A1 (fr) 2000-03-24
NL1019705C2 (nl) 2002-03-26
GB9920710D0 (en) 1999-11-03
JP2000159682A (ja) 2000-06-13
BE1012725A5 (fr) 2001-02-06
NO994463D0 (no) 1999-09-15
NL1019705A1 (nl) 2002-01-29
SE9903307D0 (sv) 1999-09-16
SE9903307L (sv) 2000-03-18
KR20000023206A (ko) 2000-04-25
ITTO990784A0 (it) 1999-09-14
FR2788697A1 (fr) 2000-07-28
CN1255376A (zh) 2000-06-07
SG76631A1 (en) 2000-11-21
ITTO990784A1 (it) 2001-03-14
SE0100195D0 (sv) 2001-01-24
GB9921387D0 (en) 1999-11-10
AU4486299A (en) 2000-03-30
GB2341800A (en) 2000-03-29
CA2282234A1 (en) 2000-03-17
DE19944695A1 (de) 2000-03-30
NL1013049C2 (nl) 2002-01-11
NL1013049A1 (nl) 2000-03-21
IT1307267B1 (it) 2001-10-30
ES2155802B1 (es) 2001-12-01
DK199901235A (da) 2000-03-18
IL131722A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
SE0100195D0 (sv) Utvärderingsförfaranden för antitumöraktivitet
TR199700358A2 (xx) �nterferon birle�imler.
BR9916857A (pt) 4 heteroaril diarilaminas
PT983286E (pt) Compostos de aminoalquil-glicosamina-fosfato e sua utilizacao como adjuvantes eimunoefectores
FR2791678B1 (fr) Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
NL1003465A1 (nl) Implanteerbare transponder en verbeterde samenstellingswerkwijze.
PT819122E (pt) Derivados de 1,3-di-hidro-1-(fenilalquil)-2h-imidazol-2-ona com actividade de pde iv e de citoquina
FR2805465B1 (fr) Nouvelles compositions pharmaceutique ou dietetiques a base de champignons
FR2809730B1 (fr) Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
TR199801871A3 (tr) Bifenilsulfonilsiyanamidler üretim yöntemi ve ilaç olarak kullanimlari.
IT1293910B1 (it) Bracciolo di sedia, e sedia utilizzante tale bracciolo.
ITRE990028A0 (it) Integratore alimentare chelato ad uso agro-zootecnico, e metodo per l' ottenimento dello stesso.
DE60006448D1 (de) Mercaptoalkohol-Verbindungen als als Geschmackstoffe
IT9022341A0 (it) Estratti da tessuti animali, utili in terapia e in diagnostica.
FR2756563B1 (fr) Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
ATE252096T1 (de) Prolylendopeptidase-inhibitoren, ihre herstellung und ihre pharmazeutische verwendung
FR2845388B1 (fr) Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
FI965064A0 (fi) Veteenliukeneva suurimolekyylinen yhdiste, joka sisältää silikonia ja sen tuotanto ja käyttö
FR2779429B1 (fr) Derives d'oxindole, leurs preparations et leurs applications en therapeutique
ATE305455T1 (de) 1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität
DE69610948D1 (de) Immunoenzymatisches konjugat, herstellungsverfahren dafür und verwendungen
EP0836480A4 (en) COMPOSITIONS THAT PROVIDE ADP-RIBOSYL TRANSFERASE ACTIVITY AND METHODS FOR THEIR PRODUCTION AND USE
IL138117A0 (en) 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them
DE69613793D1 (de) Ophthalmische Cromolyn-Gelzubereitung
WO2003060467A3 (en) Method for analyzing effects of medical agents

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 0100195-7

Format of ref document f/p: F